Biotech

All Articles

ArsenalBio raises $325M, pivots out of previous lead property

.Collection Biosciences is proceeding up. The cell treatment company has actually added on $325 mill...

Lilly- supported weight management biotech reports IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...

Aelis' marijuana usage drug fails period 2b, steering Indivior to reconsider $100M alternative

.Aelis Farma's chances of getting a simple, positive choice on a $one hundred million alternative re...

ProKidney halts period 3 trial not needed for cell therapy approval

.ProKidney has ceased among a set of period 3 trials for its own cell treatment for renal health con...

Vaxcyte rises on 'sensational' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what analysts referred to as "spectacular" period 1/2 records for its 31-valent pn...

Recursion's mind disease trial shows scant proof of efficacy

.Recursion has actually discovered with an early test of its tech-enabled technique to medication re...

Acepodia, Pfizer click all together for chemistry-based tissue treatment

.Contact it a situation of good chemical make up: Acepodia, a biotech based on Nobel Champion scienc...

Praxis epilepsy medication reduces confiscations in period 2 litigation

.Praxis Accuracy Medicines has actually racked up an additional midphase win in epilepsy this year, ...

Three officers surrender as Dyne messages combined records for DMD candidate

.After leaving a medical grip a number of years back, Dyne Therapy has disclosed new stage 1/2 data ...

Arrowhead fires off stage 3 information in unusual metabolic ailment in front of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own hand in front of a prospective face-off with Ionis, ...